Martingale Asset Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-61,384
| Closed | -$672K | – | 824 |
|
|
2023
Q4 | $672K | Sell |
61,384
-10
| -0% | -$109 | 0.01% | 538 |
|
|
2023
Q3 | $352K | Sell |
61,394
-10
| -0% | -$57 | 0.01% | 661 |
|
|
2023
Q2 | $476K | Buy |
61,404
+4,641
| +8% | +$36K | 0.01% | 627 |
|
|
2023
Q1 | $379K | Buy |
56,763
+27,900
| +97% | +$186K | 0.01% | 672 |
|
|
2022
Q4 | $258K | Buy |
28,863
+3,648
| +14% | +$32.6K | 0.01% | 743 |
|
|
2022
Q3 | $249K | Buy |
+25,215
| New | +$249K | 0.01% | 743 |
|